PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Posts navigation

1 2 … 9 Next
Pharma deals at 41st JP Morgan Healthcare conference

Pharma deals at 41st JP Morgan Healthcare conference

Against a backdrop of challenging circumstances around the globe in 2022, what do the pharma deals announced during the recent JP Morgan Healthcare conference suggest about investor sentiment and the way forward for pharma in 2023?

1 Feb 2023
Read More
MHRA ramps up assessment capacity for in-vitro diagnostic devices

MHRA ramps up assessment capacity for in-vitro diagnostic devices

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended the designation of UL International UK Ltd as an Approved Body.

30 Jan 2023
Read More
JP Morgan Healthcare conference research trends in 2023

JP Morgan Healthcare conference research trends in 2023

PMC reviews insights from the 41st JP Morgan Healthcare conference, focusing on some of the new treatments and technologies to watch out for in the pharma industry this year – and highlighting challenges to progress.

25 Jan 2023
Read More
EC adopts proposal to allow more time to certify medical devices

EC adopts proposal to allow more time to certify medical devices

Fears of a shortage of medical devices have led the European Commission (EC) to adopt a proposal to extend the transition period to new rules under the Medical Devices Regulation. The proposal was made at the EPSCO Council meeting on 9 December 2022 by EU health ministers.

23 Jan 2023
Read More
ICH webinar to update on M11 clinical trial guideline

ICH webinar to update on M11 clinical trial guideline

A free webinar on the M11 Guideline has been organised by the International Council for Harmonisation (ICH) M11 Expert Working Group (EWG). The Guideline is an initiative to promote greater harmonisation across international clinical trial protocols. The webinar takes place on 26 January 2023 at 10am-12pm EST (3-5pm GMT).

17 Jan 2023
Read More
BIA reassured by Chancellor on life science support

BIA reassured by Chancellor on life science support

The UK BioIndustry Association (BIA) appears to have won a reprieve on proposed cuts to SME R&D tax credits, via a letter from Chancellor Jeremy Hunt. The policy was introduced in the Government’s Autumn Statement in November 2022, due to take effect in April 2023.

12 Jan 2023
Read More
EMA reminder that clinical trials must use CTIS

EMA reminder that clinical trials must use CTIS

The European Medicines Agency (EMA) has issued a reminder that from 31 January 2023 clinical trial sponsors must use the Clinical Trials Information System (CTIS) for initial trial applications.

9 Jan 2023
Read More
OHE Innovation Policy Prize

OHE Innovation Policy Prize

The Office of Health Economics (OHE) launched a biennial competition in early 2022 to answer the question ‘How can policymakers design a system to generate fair prices that balances access and innovation throughout the lifecycle of medicines?’ Join the live online ceremony on 24 January 2023.

5 Jan 2023
Read More
EMA and ECDC collaborate on vaccine safety and effectiveness monitoring studies

EMA and ECDC collaborate on vaccine safety and effectiveness monitoring studies

The European Medicines Agency (EMA) and European Centre for Disease Prevention and Control (ECDC) held the first meeting of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB) of the Vaccine Monitoring Platform (VMP) in early December. Via the VMP they will coordinate and oversee EU-funded, independent post-authorisation studies on vaccines use, safety and effectiveness in EU countries.

30 Dec 2022
Read More
UK government commits over £175 million to genomics research

UK government commits over £175 million to genomics research

On 13 December 2022 the UK government announced a programme of funding for genomic research, including £105 million for diagnosis of rare genetic diseases in newborns, plus funding to improve the accuracy and speed of cancer diagnosis, and support for new technologies across the health and care system.

27 Dec 2022
Read More

Posts navigation

1 2 … 9 Next

Categories

  • Awards
  • Consultants
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #ClinicalTrials #DCVMN #diagnostics #drugdevelopment #drugpricing #EC #EMA #EU #FDA #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #mentalhealth #mhra #NICE #outsourcing #PatientAccess #pharmaregulation #pharmatrends #projectorbis #quality #rarediseases #regulation #regulatory #ukpharma AI Biotech Capabilities Brochure Clinical Research Clinical Resourcing COVID-19 CRO DITTurkey Drug Price Healthcare Medical Affairs medicaldevices Patient Care Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital